Teresa Fasciana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Teresa Fasciana has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Cortegiani
Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), University of Palermo, Palermo, Italy
1 shared publication - Anna Giammanco
Legionella Reference Laboratory, University of Palermo, 90127 Palermo, Italy
1 shared publication - Antonino Giarratano
Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), University of Palermo, 90127 Palermo, Italy
1 shared publication - Anuradha Chowdhary
Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi
1 shared publication - Giovanni Misseri
Department of Anaesthesia and Intensive Care, Fondazione Istituto “G.Giglio” Cefalù, 90015 Palermo, Italy
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 29 October 2018
- Published by Springer Nature in Journal of Intensive Care
- Vol. 6 (1) , 1-13
Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris
Candida spp. infections are a major cause of morbidity and mortality in critically ill patients. Candida auris is an emerging multi-drug-resistant fungus that is rapidly spreading worldwide. Since the first reports in 2009, many isolates across five continents have been identified as agents of hospital-associated infections. Independent and simultaneous outbreaks of C. auris are becoming a major concern for healthcare and scientific community. Moreover, laboratory misidentification and multi-drug-resistant profiles, rarely observed for other non-albicans Candida species, result in difficult eradication and frequent therapeutic failures of C. auris infections. The aim of this review was to provide an updated and comprehensive report of the global spread of C. auris, focusing on clinical and microbiological characteristics, mechanisms of virulence and antifungal resistance, and efficacy of available control, preventive, and therapeutic strategies.
- 29 October 2018
- Published by Springer Nature in Journal of Intensive Care
- Vol. 6 (1) , 1-13
Top Cited PapersOpen AccessEpidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris
Candida spp. infections are a major cause of morbidity and mortality in critically ill patients. Candida auris is an emerging multi-drug-resistant fungus that is rapidly spreading worldwide. Since the first reports in 2009, many isolates across five continents have been identified as agents of hospital-associated infections. Independent and simultaneous outbreaks of C. auris are becoming a major concern for healthcare and scientific community. Moreover, laboratory misidentification and multi-drug-resistant profiles, rarely observed for other non-albicans Candida species, result in difficult eradication and frequent therapeutic failures of C. auris infections. The aim of this review was to provide an updated and comprehensive report of the global spread of C. auris, focusing on clinical and microbiological characteristics, mechanisms of virulence and antifungal resistance, and efficacy of available control, preventive, and therapeutic strategies.